CRUK Consent Forms – Bladder cancer immunotherapy regimens

Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website.

A new form for Nivolumab has been added.

Revalidation of the remaining regimen specific consent forms are in progress and will be updated in due course.

All forms can be found at www.cruk.org/sact_consent.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA on 8th September 2026

Register now: Immunotherapy: Beyond Checkpoint Inhibitors

Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE:  Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…

Read article
By BOPA Executive Committee on 7th September 2026

Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway

We are delighted to see the Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway today. This curriculum is the product of a truly collaborative effort across…

Read article
By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article